Related Experiment Videos
2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors
P Imbach1, H G Capraro, P Furet
1Novartis Pharmaceuticals, Novartis Limited, Basel, Switzerland.
Bioorganic & Medicinal Chemistry Letters
|February 17, 1999
Abstract:
Novel 2,6,9-substituted purine derivatives represent a class of potent and selective inhibitors of CDK1/cyclinB. The synthesis, SAR and biological profile of selected compounds are described.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A retinotopic wiring principle of the human brain.
bioRxiv : the preprint server for biology·2026
Discovery of novel dual STAT3/TrxR1 inhibitors via pharmacophore fusion as potent lead compounds for colorectal cancer.
Bioorganic & medicinal chemistry letters·2026
Efficient PNA double-duplex invasion using preQ1•G-clamp as a pseudo-complementary G•C base pair.
Bioorganic & medicinal chemistry letters·2026
Reactivation of an inert 15-mer antimicrobial peptide by truncation-directed i, i + 7 lactam cyclization.
Bioorganic & medicinal chemistry letters·2026
Semi-synthesis and activity study of α-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD.
Bioorganic & medicinal chemistry letters·2026
Caffeic acid phenethyl ester derivatives inhibit glyoxalase I activity and induce cell death in cultured cancer cell lines.
Bioorganic & medicinal chemistry letters·2026
Acetazolamide use in idiopathic intracranial hypertension: a real-world cohort study of side effects.
Expert review of neurotherapeutics·2026